Manabu Ogita

2.9k total citations
98 papers, 1.6k citations indexed

About

Manabu Ogita is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Manabu Ogita has authored 98 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Cardiology and Cardiovascular Medicine, 56 papers in Surgery and 21 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Manabu Ogita's work include Acute Myocardial Infarction Research (33 papers), Coronary Interventions and Diagnostics (31 papers) and Lipoproteins and Cardiovascular Health (27 papers). Manabu Ogita is often cited by papers focused on Acute Myocardial Infarction Research (33 papers), Coronary Interventions and Diagnostics (31 papers) and Lipoproteins and Cardiovascular Health (27 papers). Manabu Ogita collaborates with scholars based in Japan, Egypt and United States. Manabu Ogita's co-authors include Katsumi Miyauchi, Hiroyuki Daida, Tomotaka Dohi, Takatoshi Kasai, Shinya Okazaki, Shuta Tsuboi, Ryo Naito, Hirokazu Konishi, Kikuo Isoda and Hideki Wada and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Manabu Ogita

91 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manabu Ogita Japan 23 846 655 227 226 225 98 1.6k
Satoru Suwa Japan 23 853 1.0× 580 0.9× 186 0.8× 171 0.8× 201 0.9× 110 1.5k
Nicola Cosentino Italy 25 937 1.1× 552 0.8× 99 0.4× 129 0.6× 183 0.8× 133 2.0k
Adnan Abacı Türkiye 21 1.0k 1.2× 459 0.7× 183 0.8× 253 1.1× 276 1.2× 91 2.0k
Alon Schaffer Italy 25 950 1.1× 537 0.8× 76 0.3× 287 1.3× 189 0.8× 80 1.8k
Avinainder Singh United States 22 762 0.9× 388 0.6× 246 1.1× 107 0.5× 129 0.6× 62 1.5k
Çağrı Yayla Türkiye 25 792 0.9× 317 0.5× 132 0.6× 481 2.1× 406 1.8× 116 1.7k
Hoong Sern Lim United Kingdom 25 1.1k 1.3× 625 1.0× 93 0.4× 171 0.8× 277 1.2× 122 2.2k
Anthony L. Pucillo United States 15 910 1.1× 505 0.8× 250 1.1× 181 0.8× 290 1.3× 53 1.7k
Shuta Tsuboi Japan 18 522 0.6× 399 0.6× 161 0.7× 156 0.7× 140 0.6× 52 957
Nihat Şen Türkiye 23 741 0.9× 324 0.5× 137 0.6× 515 2.3× 349 1.6× 85 1.7k

Countries citing papers authored by Manabu Ogita

Since Specialization
Citations

This map shows the geographic impact of Manabu Ogita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manabu Ogita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manabu Ogita more than expected).

Fields of papers citing papers by Manabu Ogita

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manabu Ogita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manabu Ogita. The network helps show where Manabu Ogita may publish in the future.

Co-authorship network of co-authors of Manabu Ogita

This figure shows the co-authorship network connecting the top 25 collaborators of Manabu Ogita. A scholar is included among the top collaborators of Manabu Ogita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manabu Ogita. Manabu Ogita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iwata, Hiroshi, Shinichiro Doi, Hideki Wada, et al.. (2025). Prognostic impact of proteinuria in diabetic patients without chronic kidney disease undergoing percutaneous coronary intervention. PubMed. 11(1). 34–34.
2.
Moriya, S, Hiroshi Iwata, Shinichiro Doi, et al.. (2023). Synergistic adverse impact of diabetes and chronic kidney disease on cardiovascular mortality in patients underwent percutaneous coronary intervention. European Heart Journal. 44(Supplement_2).
3.
Wada, Hideki, Manabu Ogita, Yuta Takamura, et al.. (2023). Clinical outcomes of ST elevation myocardial infarction patients without standard modifiable risk factors. Journal of Cardiology. 84(1). 41–46. 1 indexed citations
4.
Yamamoto, Ko, Takeshi Morimoto, Masahiro Natsuaki, et al.. (2023). Statin Discontinuation After Coronary Revascularization. The American Journal of Cardiology. 207. 479–489. 2 indexed citations
5.
Iwata, Hiroshi, Shinichiro Doi, Hirohisa Endo, et al.. (2022). A Prognostic Merit of Statins in Patients with Chronic Hemodialysis after Percutaneous Coronary Intervention—A 10-Year Follow-Up Study. Journal of Clinical Medicine. 11(2). 390–390. 5 indexed citations
7.
Wada, Hideki, et al.. (2020). Successful surgical transmitral removal of left ventricular thrombus after acute anterior myocardial infarction without left ventriculotomy. Journal of Cardiology Cases. 23(1). 24–26. 2 indexed citations
8.
Shitara, Jun, Takatoshi Kasai, Hirokazu Konishi, et al.. (2019). Impact of Lipoprotein (a) Levels on Long-Term Outcomes in Patients With Coronary Artery Disease and Left Ventricular Systolic Dysfunction. Circulation Journal. 83(5). 1047–1053. 16 indexed citations
9.
Wada, Hideki, Tomotaka Dohi, Katsumi Miyauchi, et al.. (2019). Impact of serum 1,5-anhydro-d-glucitol level on the prediction of severe coronary artery calcification: an intravascular ultrasound study. Cardiovascular Diabetology. 18(1). 69–69. 16 indexed citations
10.
Shitara, Jun, Takatoshi Kasai, Shoichiro Yatsu, et al.. (2019). Effects of suvorexant on sleep apnea in patients with heart failure: A protocol of crossover pilot trial. Journal of Cardiology. 74(1). 90–94. 3 indexed citations
11.
Endo, Hirohisa, Tomotaka Dohi, Jun Shitara, et al.. (2018). Impact of body mass index on long-term outcomes in Japanese patients following percutaneous coronary intervention: The Juntendo PCI Registry. Journal of Cardiology. 72(3). 208–214. 9 indexed citations
12.
Konishi, Hirokazu, Katsumi Miyauchi, Hideki Wada, et al.. (2017). Abstract 15623: Effect of Pemafibrate (k-877), a Novel Selective Peroxisome Proliferator-activated Receptor α Modulator (spparmα), in Atherosclerosis Model Using Low Density Lipoprotein Receptor Knock-out Swine With Balloon Injury. Circulation. 2 indexed citations
13.
14.
Wada, Hideki, Manabu Ogita, Katsumi Miyauchi, et al.. (2016). Case report: Fulminant myocarditis associated with overwhelming pneumococcal infection. International Journal of Cardiology. 223. 706–707. 2 indexed citations
16.
Chan, Mark Y., Xin Du, D. Eccleston, et al.. (2015). Acute coronary syndrome in the Asia-Pacific region. International Journal of Cardiology. 202. 861–869. 80 indexed citations
17.
Konishi, Hirokazu, Katsumi Miyauchi, Takatoshi Kasai, et al.. (2014). Long-term prognosis and clinical characteristics of young adults (≤40 years old) who underwent percutaneous coronary intervention. Journal of Cardiology. 64(3). 171–174. 22 indexed citations
18.
Konishi, Hirokazu, Katsumi Miyauchi, Takatoshi Kasai, et al.. (2014). Impact of Lipoprotein(a) as Residual Risk on Long-Term Outcomes in Patients After Percutaneous Coronary Intervention. The American Journal of Cardiology. 115(2). 157–160. 45 indexed citations
20.
Ogita, Manabu, Tomohiro Nakamura, Naoki Fujiwara, et al.. (2009). Long‐Term Clinical Follow‐up after Sirolimus‐Eluting Stent versus Bare Metal Stent Implantation in Patients with Acute Coronary Syndrome. Journal of Interventional Cardiology. 22(3). 216–221. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026